Race for a monkeypox cure: major trial tests promising antiviral
NCT ID NCT05559099
Summary
This study tested whether a drug called tecovirimat helps people with monkeypox get better faster. Nearly 600 adults and children with confirmed monkeypox were randomly given either the real drug or a placebo pill, along with standard hospital care, for two weeks. Researchers tracked how quickly skin lesions healed and monitored safety to see if the treatment effectively controls the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
L'Hôpital Général de Référence de Kole
Kole, Democratic Republic of the Congo
-
L'Hôpital Général de Référence de Tunda
Tunda, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.